uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. - Wikidata - thesis-toulmin - TriplyDB

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.

http://www.wikidata.org/entity/Q30443804

about

HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180.Urokinase receptor and resistance to targeted anticancer agents Epithelial-mesenchymal plasticity in carcinoma metastasis Calcium influx pathways in breast cancer: opportunities for pharmacological intervention Non-stimulated, agonist-stimulated and store-operated Ca2+ influx in MDA-MB-468 breast cancer cells and the effect of EGF-induced EMT on calcium entry The Regulatory Role of MicroRNAs in EMT and Cancer uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages.Differential roles of uPAR in peritoneal ovarian carcinomatosis Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization.PLAUR polymorphisms and lung function in UK smokers.Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form.Mechanisms of the epithelial-mesenchymal transition by TGF-beta EPS8 upregulates FOXM1 expression, enhancing cell growth and motility Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.DNAJB6 induces degradation of beta-catenin and causes partial reversal of mesenchymal phenotype.Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway Knockdown of β-Catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1α.Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells Multilayer control of the EMT master regulators.Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-{beta}.Oxygen-Dependent Gene Expression in Development and Cancer: Lessons Learned from the Wilms' Tumor Gene, WT1 Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism.Implication of snail in metabolic stress-induced necrosis.Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection.In vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancer Resveratrol targets transforming growth factor-β2 signaling to block UV-induced tumor progression.Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells.Chick Chorioallantoic Membrane Assay: A 3D Animal Model for Study of Human Nasopharyngeal Carcinoma Plectin as a prognostic marker in non-metastatic oral squamous cell carcinoma Interplay between β1-integrin and Rho signaling regulates differential scattering and motility of pancreatic cancer cells by snail and Slug proteins.Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition.A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity.Docosahexaenoic Acid Inhibits Tumor Promoter-Induced Urokinase-Type Plasminogen Activator Receptor by Suppressing PKCδ- and MAPKs-Mediated Pathways in ECV304 Human Endothelial Cells.Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report.Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer

P2860

Q24338405-DE95C85F-98A4-4BE7-8610-4A68FB672AF7 Q24642555-B82A3E05-5924-464E-8946-580531342B00 Q26797385-40FC3528-EFEA-45AA-B3DC-F563EF35B605 Q26859804-E6211AF2-3491-4004-B185-35742E467F7D Q27025564-6A623F49-6065-40FB-BB46-199A91015A13 Q27303027-FD0C35D3-A4E5-4FE2-AEBB-A28F3467A371 Q28391426-85D90795-B18C-4B51-A3A0-698140D5A712 Q30365899-309EA16D-AB37-43AA-873B-D35F511F9C0A Q30426956-B753F1A6-86D0-40DD-9652-4CEC4704DF1C Q30571243-F9A29CB3-C566-4274-BF76-1E0250E340E7 Q33495586-03812198-9618-432F-8388-639FB806A8D3 Q33514135-8D333FFD-A953-4061-B52A-30715460A71C Q33709060-4D03717F-1761-4230-B749-359042EAC925 Q33728631-4885CA62-352D-4313-AEA9-BAB0954454FE Q33804105-CA301ABB-AA9A-4BA3-BBCE-0537874C3E13 Q33884598-15030E5C-DF1E-4993-BD90-911AE8E6E1C8 Q33953134-378DB4EE-45F0-4557-BCB8-5DB7A4DF317B Q34042660-C91D7FB8-5806-4C1E-A545-125E63F473CB Q34048106-178E227F-1826-43F0-90BC-9ACB28C6BB07 Q34190465-6B71AFBD-A742-4F9B-AA55-F0703924A2AB Q34267846-8F9066DE-AAD7-43FD-AC6C-D1CDB1AE23F0 Q34340552-DCF4C0E7-12AC-4836-A8FE-E1BA86C52F8F Q34352884-DAA18B18-ACCB-4193-AB1B-2AFB46C95AA6 Q34617481-433444B0-F8CC-4974-B7F2-03FE8F90E936 Q34701603-0F7D4B6B-FD54-4CF7-832C-9F1CB3E30383 Q34713056-279EF68C-5731-4BCC-84A6-4D0475865E07 Q34750035-CA611317-9C79-4577-823C-B30E7A3A2D2C Q34997475-933494CA-31A7-4AE6-BA9F-93F86E9000CC Q35156138-59F84FD9-75CF-4B33-8E3C-4B2749BB7489 Q35387417-9D5AF635-7DB7-411C-8044-7B00BBBB85DD Q35673298-68F1EF3F-A197-4F4B-A734-FC7C14B30273 Q35755113-F1A04232-AA81-4C25-BAC1-F7A1BE7629A4 Q35839019-E468266C-5DF7-4DD3-B8E2-06A5650FD149 Q35852067-38C4A7F0-16CD-49E9-A949-EF782E2FE367 Q36059078-C11010AD-AB10-43F3-AD4A-C8C8C403BE1C Q36094119-EC3D2997-C6FB-4DFF-85CA-78BBB448ADA1 Q36139904-81D74576-5994-4B27-9878-2123FFCA3D4D Q36168520-7212FB98-D5EE-4EED-BB88-1F6C79A7F410 Q36181216-F97C7951-4624-438A-9DC1-2BFC076D8409 Q36201682-35ED92E7-A256-4A01-862D-D0F9EB12E1B7

P2860

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.

http://www.wikidata.org/entity/Q30443804

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.

@ast

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.

@en

type

label

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.

@ast

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.

@en

prefLabel

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.

@ast

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.

@en

P1433

Q30443804-E508EF40-4D79-459A-BAD4-00C5FC3D8594

P1476

Q30443804-3C6ACADA-60E0-4567-81AE-68E9E2E8035E

P2093

Q30443804-6CC009FA-8085-490D-B6DD-FEAAC13D4BA2

Q30443804-96D5EF13-8F28-459E-A73A-3614A5D62DA0

Q30443804-9C333EBA-6069-402B-A1EC-3962BFA7CD00

Q30443804-DCF0DFC4-299B-46CA-93C5-9FAE988AE8E2

P2860

Q30443804-021E437E-4471-49A1-BFD7-C1D40B2B0EA3

Q30443804-04F8B288-85F9-4897-BD4D-028D8C9051CB

Q30443804-08D60AA3-CF2F-49AC-AB76-C43B9C67DB05

Q30443804-0B1B9FFF-99B1-4E2C-B5D9-D3240825E210

Q30443804-0CBC8552-2721-4E04-B48E-C01B4FD153C0

Q30443804-1CEFE8C5-E5E4-40A1-81C1-6ED867D03EB5

Q30443804-1F2FE91A-DDC8-4F98-809C-3625CB3DEB7B

Q30443804-2283A157-AD97-48D5-81FA-7631D2E3B495

Q30443804-25F90BA2-7CC1-4210-9604-D0FF197F8D8A

Q30443804-2A604B8C-A551-4302-938C-48C83287E748

P304

Q30443804-160217B1-69EA-4018-865B-0F719ED737E5

P31

Q30443804-0D05E5E0-AEF9-4623-BEC0-DF1DD5A52D29

P356

Q30443804-9FFED0B6-C31B-471B-BC0F-4C51CB60C89F

P407

Q30443804-5E13E4D4-74F7-46B0-8454-DC77352C47AB

P433

Q30443804-4D556E8B-A1E9-41FD-8CE7-47CB7E0545F8

P478

Q30443804-A5690D74-BC93-4F0A-B166-1F62F7366EEA

P50

Q30443804-342D4AB4-D53F-41B0-9B9F-44155AC7A156

P577

Q30443804-B611F21A-D3E2-4495-8888-C2C0118B0AD5

P5875

Q30443804-04F50A5A-4DFE-45F5-A4CE-2426683D53C3

P698

Q30443804-6679D91B-2E73-4F7A-945A-8FA77509A5C1

P921

Q30443804-D44D4457-D19F-46DC-B899-1EE1BE0F3A25

P932

Q30443804-155542E7-D47B-439C-8882-4055BF8392FC

P356

P1433

Journal of Cell Biology

P1476

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.

@en

P2093

Minji Jo

http://www.w3.org/2001/XMLSchema#string

Robin D Lester

http://www.w3.org/2001/XMLSchema#string

Shinako Takimoto

http://www.w3.org/2001/XMLSchema#string

Steven L Gonias

http://www.w3.org/2001/XMLSchema#string

P2860

Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition

General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta

A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function

Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells

Epithelial-mesenchymal transitions in tumour progression

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

The snail superfamily of zinc-finger transcription factors

P304

425-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.200701092

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

Valérie Montel

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6175493

http://www.w3.org/2001/XMLSchema#string

P698

17664334

http://www.w3.org/2001/XMLSchema#string

P921

P932

2064849

http://www.w3.org/2001/XMLSchema#string